Target intelligence / Profile preview

G protein-coupled receptor 85 (GPR85)

Target
GPR85
Molecular classification
G protein-coupled receptor (GPCR), Class A GPCR (Rhodopsin-like), Transmembrane receptor
01

Overview

G protein-coupled receptor 85 (GPR85), also known as SREB2, is a highly conserved member of the GPCR superfamily, specifically within the Rhodopsin-like Class A subfamily. It possesses a seven transmembrane domain architecture typical of GPCRs and is abundantly expressed in regions of the brain linked to synaptic plasticity, notably the hippocampal dentate gyrus. GPR85 is unique for its near-absolute evolutionary conservation across vertebrates, suggesting critical functional significance. Experimental data indicate that GPR85 plays a role in brain development, behavior regulation, and cognitive processes. Overexpression in transgenic mice leads to reduced brain weight and behavioral abnormalities resembling psychiatric illnesses, while knockout increases brain weight and may enhance memory. Human genetic studies associate GPR85 variants with susceptibility to schizophrenia and reduced hippocampal volume. GPR85 remains an orphan receptor, with no known endogenous ligand or drug therapies directly targeting it, but its pathway is considered a promising target for neuropsychiatric drug development.

Other names
SREB2Probable G-protein coupled receptor 85Super conserved receptor expressed in brain 2SREBSeven transmembrane helix receptorPutative G protein-coupled receptor 85
02

Mechanism of action

Presumed modulation of neural integrity and plasticity via G protein-coupled signal transduction. When targeted, GPCRs generally act through heterotrimeric G protein signaling cascades, affecting second messenger generation (as for related Class A GPCRs)

03

Biological functions

Signal transductionModulation of neuronal plasticityRegulation of brain sizeInfluence on memory and social behavior
04

Disease associations

Psychiatric disorders (schizophrenia risk and cognitive dysfunction)Autism spectrum disorderPotential involvement in neurodegenerative disease (supported by GPCR family context, but direct evidence for GPR85 still limited)
05

Safety considerations

No specific safety concerns reported, but modulating GPR85 expression in animal models leads to changes in brain size and behavior, suggesting possible effects on CNS structure/function
06

Interacting drugs

None with proven interaction; GPR85 is considered an orphan receptor with no known endogenous ligand or approved drugs
07

Biomarkers

Two SREB2/GPR85 SNPs in intron 2 and 3′ UTR may serve as low-specificity biomarkers for schizophrenia risk and reduced hippocampal gray matter volume

Beyond the preview

Go deeper on G protein-coupled receptor 85 (GPR85).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor 85 (GPR85).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call